Clinical Trial Update: The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI [Phase 4]

View source ↗

Summary

A Phase 4 trial update examining the combination of ticagrelor with low molecular weight heparin during PCI, with notes on a potential interaction between lovas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Enoxaparin (enoxaparin sodium)
• Lovastatin (Lovastatin)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: LOVASTATIN/TICAGRELOR [VA Drug Interaction] | Phase 4 | Status: UNKNOWN